Ionosol Mb And Dextrose Injection, Solution
NDC Package 0990-7372-03
Package Information
Ionosol Mb And Dextrose (dextrose monohydrate, sodium lactate, potassium chloride, magnesium chloride, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydrate) injection is ionosol MB and 5% Dextrose Injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 mL of 5% dextrose and 0.45% Sodium Chloride Injection/kg of body weight.In adults, Ionosol MB and 5% Dextrose Injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy, with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves. This formulation utilizes a injection, solution delivery system. Marketed by Icu Medical Inc., this product is identified by NDC 0990-7372 and is authorized under FDA application NDA019513.
Identification & Billing
- RxCUI: 800644 - electrolyte-MB in 5 % dextrose Injectable Solution
- RxCUI: 800644 - glucose 50 MG/ML / magnesium chloride 0.00361 MEQ/ML / monobasic potassium phosphate 0.15 MG/ML / potassium chloride 0.0189 MEQ/ML / sodium lactate 0.0232 MEQ/ML / sodium phosphate, monobasic 0.25 MG/ML Injectable Solution
- RxCUI: 800644 - Glucose 50 MG/ML / Magnesium Chloride 0.00361 MEQ/ML / Monobasic K+ phosphate 0.15 MG/ML / K+ Chloride 0.0189 MEQ/ML / Sodium Lactate 0.0232 MEQ/ML / Sodium Phosphate, Monobasic 0.25 MG/ML Injectable Solution
- RxCUI: 800644 - Glucose 50 MG/ML / Magnesium Chloride 0.00361 MEQ/ML / Monobasic Pot phosphate 0.15 MG/ML / Pot Chloride 0.0189 MEQ/ML / Sodium Lactate 0.0232 MEQ/ML / Sodium Phosphate, Monobasic 0.25 MG/ML Injectable Solution
- RxCUI: 800648 - IONOSOL MB and 5 % DEXTROSE Injectable Solution
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0990 - Icu Medical Inc.
- 0990-7372 - Ionosol Mb And Dextrose
- 0990-7372-03 - 24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 500 mL in 1 BAG
- 0990-7372 - Ionosol Mb And Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0990-7372). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0990-7372-03 identifies a specific commercial package of 24 pouch in 1 case / 1 bag in 1 pouch / 500 ml in 1 bag of Ionosol Mb And Dextrose, a human prescription drug labeled by Icu Medical Inc.. This injection, solution is formulated for intravenous use and contains dextrose monohydrate; magnesium chloride; monobasic potassium phosphate; potassium chloride; sodium lactate; sodium phosphate, monobasic, monohydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Icu Medical Inc. on July 01, 2019. The current certification is valid through December 31, 2027.
How is this Icu Medical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00990737203. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.